CLINICAL_TRIALS
trial_result
· 2026-07-27
Clinical Trial Results: Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis [Phase 3]
Summary
Long-term extension study assessing safety and efficacy of filgotinib in adults with rheumatoid arthritis (Phase 3) has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alfasigma S.p.A. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2026-07-27